SG11201703292VA - ANTI HUMAN Gas6 MONOCLONAL ANTIBODY - Google Patents
ANTI HUMAN Gas6 MONOCLONAL ANTIBODYInfo
- Publication number
- SG11201703292VA SG11201703292VA SG11201703292VA SG11201703292VA SG11201703292VA SG 11201703292V A SG11201703292V A SG 11201703292VA SG 11201703292V A SG11201703292V A SG 11201703292VA SG 11201703292V A SG11201703292V A SG 11201703292VA SG 11201703292V A SG11201703292V A SG 11201703292VA
- Authority
- SG
- Singapore
- Prior art keywords
- monoclonal antibody
- anti human
- human gas6
- gas6 monoclonal
- antibody
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/32—Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462066687P | 2014-10-21 | 2014-10-21 | |
| PCT/JP2015/005291 WO2016063522A1 (ja) | 2014-10-21 | 2015-10-20 | 抗ヒトＧａｓ６モノクローナル抗体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201703292VA true SG11201703292VA (en) | 2017-06-29 |
Family
ID=55760581
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201703292VA SG11201703292VA (en) | 2014-10-21 | 2015-10-20 | ANTI HUMAN Gas6 MONOCLONAL ANTIBODY |
| SG10201903424RA SG10201903424RA (en) | 2014-10-21 | 2015-10-20 | ANTI HUMAN Gas6 MONOCLONAL ANTIBODY |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201903424RA SG10201903424RA (en) | 2014-10-21 | 2015-10-20 | ANTI HUMAN Gas6 MONOCLONAL ANTIBODY |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10561727B2 (ja) |
| EP (1) | EP3211080B1 (ja) |
| JP (1) | JP6803231B2 (ja) |
| KR (1) | KR20170070228A (ja) |
| CN (1) | CN107148474B (ja) |
| AU (1) | AU2015334389B2 (ja) |
| CA (1) | CA2965459A1 (ja) |
| ES (1) | ES2824480T3 (ja) |
| SG (2) | SG11201703292VA (ja) |
| TW (1) | TWI707868B (ja) |
| WO (1) | WO2016063522A1 (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210148932A1 (en) * | 2017-06-26 | 2021-05-20 | Eiken Kagaku Kabushiki Kaisha | Method for measuring serum amyloid a of various animals and reagent for measurement thereof |
| WO2020186256A1 (en) * | 2019-03-14 | 2020-09-17 | Aravive Inc | Methods of treating immunoglobulin a nephropathy (igan) using axl decoy receptors |
| CN115991770A (zh) * | 2022-05-11 | 2023-04-21 | 迈威(上海)生物科技股份有限公司 | 抗人gas6抗体或其抗原结合片段及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003304180A1 (en) | 2002-09-24 | 2005-01-04 | Dow, Kenneth, Centocor, Inc. | Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses |
| KR101951410B1 (ko) | 2010-01-22 | 2019-02-26 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 항-전이성 요법에서 ａｘｌ 신호전달의 저해 |
| BR112013032899A2 (pt) | 2011-06-22 | 2017-01-24 | Inserm Inst Nat De La Santé Et De La Rech Médicale | anticorpos anti-axl e utilizações dos mesmos |
| US9879061B2 (en) | 2011-12-15 | 2018-01-30 | The Board Of Trustees Of The Leland Stanford Junior University | Inhibition of AXL/GAS6 signaling in the treatment of liver fibrosis |
| WO2014035828A2 (en) * | 2012-08-27 | 2014-03-06 | The Board Of Trustees Of The Leland Stanford Junior University | Inhibition of axl signaling in anti-metastatic therapy |
-
2015
- 2015-10-20 JP JP2016555085A patent/JP6803231B2/ja active Active
- 2015-10-20 AU AU2015334389A patent/AU2015334389B2/en not_active Ceased
- 2015-10-20 SG SG11201703292VA patent/SG11201703292VA/en unknown
- 2015-10-20 SG SG10201903424RA patent/SG10201903424RA/en unknown
- 2015-10-20 CA CA2965459A patent/CA2965459A1/en not_active Abandoned
- 2015-10-20 EP EP15853067.5A patent/EP3211080B1/en active Active
- 2015-10-20 ES ES15853067T patent/ES2824480T3/es active Active
- 2015-10-20 KR KR1020177013557A patent/KR20170070228A/ko not_active Application Discontinuation
- 2015-10-20 WO PCT/JP2015/005291 patent/WO2016063522A1/ja active Application Filing
- 2015-10-20 CN CN201580057437.1A patent/CN107148474B/zh active Active
- 2015-10-20 US US15/520,623 patent/US10561727B2/en not_active Expired - Fee Related
- 2015-10-21 TW TW104134584A patent/TWI707868B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| CN107148474B (zh) | 2021-07-20 |
| KR20170070228A (ko) | 2017-06-21 |
| JPWO2016063522A1 (ja) | 2017-07-27 |
| SG10201903424RA (en) | 2019-05-30 |
| TW201625682A (zh) | 2016-07-16 |
| JP6803231B2 (ja) | 2020-12-23 |
| CN107148474A (zh) | 2017-09-08 |
| WO2016063522A1 (ja) | 2016-04-28 |
| EP3211080B1 (en) | 2020-09-16 |
| AU2015334389B2 (en) | 2021-08-12 |
| EP3211080A4 (en) | 2018-05-16 |
| US10561727B2 (en) | 2020-02-18 |
| AU2015334389A1 (en) | 2017-05-18 |
| TWI707868B (zh) | 2020-10-21 |
| EP3211080A1 (en) | 2017-08-30 |
| ES2824480T3 (es) | 2021-05-12 |
| US20180339041A1 (en) | 2018-11-29 |
| CA2965459A1 (en) | 2016-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202003742B (en) | Anti-lag3 antibodies and antigen-binding fragments | |
| IL251537A0 (en) | Human anti-ox40 antibodies and their uses | |
| IL250415A0 (en) | Antibodies against pd-l1 | |
| IL284291A (en) | Anti-acth antibodies from humans and their use | |
| IL248402B (en) | Humanized antibodies against ceacam1 | |
| PT3101131T (pt) | Anticorpo antitranstirretina humanizado | |
| IL256097A (en) | Antibody epitope | |
| IL247285A0 (en) | Monoclonal antibodies against the Marburg virus | |
| PT3101132T (pt) | Anticorpo humano anti-transtirretina | |
| HUE059732T2 (hu) | Humanizált Clever-1 elleni antitestek és alkalmazásuk | |
| PL3180356T3 (pl) | Ludzkie przeciwciało anty-fgfr4 | |
| GB201410520D0 (en) | Antibody | |
| HK1212719A1 (zh) | 全人源抗 抗體 | |
| SG11201703292VA (en) | ANTI HUMAN Gas6 MONOCLONAL ANTIBODY | |
| GB201418781D0 (en) | Antibody epitope | |
| GB201418776D0 (en) | Antibody | |
| GB201413745D0 (en) | Antibody | |
| GB201411319D0 (en) | Antibody | |
| GB201407535D0 (en) | Antibody Drug - Conjugates |